N,N'-Carbonyldiimidazole (CDI) Market Share, Sales Volume, Price Analysis Report 2026
On Apr 13, Global Info Research released "Global N,N'-Carbonyldiimidazole (CDI) Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032". This report includes an overview of the development of the N,N'-Carbonyldiimidazole (CDI) industry chain, the market status of N,N'-Carbonyldiimidazole (CDI) Market, and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of N,N'-Carbonyldiimidazole (CDI).
According to our (Global Info Research) latest study, the global N,N'-Carbonyldiimidazole (CDI) market size was valued at US$ 23.22 million in 2025 and is forecast to a readjusted size of US$ 27.71 million by 2032 with a CAGR of 3.1% during review period. N,N′-Carbonyldiimidazole (also written as 1,1′-carbonyldiimidazole, abbreviated as CDI; CAS 530-62-1, molecular formula C₇H₆N₄O) is a versatile reagent used in numerous chemical synthesis processes as a safer equivalent to phosgene. It functions as an efficient coupling and activation agent in the formation of amides, esters, and carbonyl compounds. Due to its stability and reliable performance, it is widely applied in pharmaceutical and industrial production, making it a valuable intermediate in fine and specialty chemical manufacturing. In 2025, global production of N,N′-Carbonyldiimidazole (CDI) reached approximately 1,328 tons, with an average global market price of around US$ 17/kg. The gross profit margin is approximately 20%-30%. Gradual growth, niche scale: CDI demand typically expands at a moderate pace because it is tied to specific synthesis routes (pharma intermediates, peptides) rather than broad commodity uses. Often campaign / make-to-order production: Many suppliers prefer to organize production by batch/order rather than large-scale upfront stockpiling. Substitution competition is real in amide/peptide coupling: CDI competes with alternative coupling strategies and reagents (e.g., T3P, HATU in some settings) and with process designs aiming to reduce coupling-reagent usage. Development speed varies across regions: Asia-Pacific growth is expected to be faster, led by China and India. In parallel, the market shows increasing China/India-based supply depth, supporting faster regional expansion. Technology trend: Better yield and waste reduction via imidazole recycle loops. Patented industrial routes emphasize neutralizing the imidazole·HCl by-product and recycling imidazole back into CDI production, targeting cost reduction and more sustainable operations. This report is a detailed and comprehensive analysis for global N,N'-Carbonyldiimidazole (CDI) market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Sample Report Request N,N'-Carbonyldiimidazole (CDI)
https://www.globalinforesearch.com/reports/3624566/n-n--carbonyldiimidazole--cdi
Market segment by Type: Purity≥98%、 Purity＜98%
Market segment by Application: Pharmaceuticals、 Peptide Synthesis、 Others
Major players covered: Lanxess、 Hodogaya Chemical、 Atul、 GREEN Life Science、 Jiangxi Jinkai Chemical、 Zhejiang HuTu PharmChem、 Holdenchem、 Jiangsu Zhenri Chemical
Market segment by region, regional analysis covers:
North America (United States, Canada and Mexico),
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe),
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia),
South America (Brazil, Argentina, Colombia, and Rest of South America),
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa).
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe N,N'-Carbonyldiimidazole (CDI) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of N,N'-Carbonyldiimidazole (CDI), with price, sales, revenue and global market share of N,N'-Carbonyldiimidazole (CDI) from 2021 to 2025.
Chapter 3, the N,N'-Carbonyldiimidazole (CDI) competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the N,N'-Carbonyldiimidazole (CDI) breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2021 to 2025.and N,N'-Carbonyldiimidazole (CDI) market forecast, by regions, type and application, with sales and revenue, from 2026 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of N,N'-Carbonyldiimidazole (CDI).
Chapter 14 and 15, to describe N,N'-Carbonyldiimidazole (CDI) sales channel, distributors, customers, research findings and conclusion.
Data Sources:
Via authorized organizations:customs statistics, industrial associations, relevant international societies, and academic publications etc.
Via trusted Internet sources.Such as industry news, publications on this industry, annual reports of public companies, Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), Trading Economics, News Network, Statista, Federal Reserve Economic Data, BIS Statistics, ICIS, Companies House Documentsm, investor presentations, SEC filings of companies, etc.
Via interviews. Our interviewees includes manufacturers, related companies, industry experts, distributors, business (sales) staff, directors, CEO, marketing executives, executives from related industries/organizations, customers and raw material suppliers to obtain the latest information on the primary market;
Via data exchange. We have been consulting in this industry for 16 years and have collaborations with the players in this field. Thus, we get access to (part of) their unpublished data, by exchanging with them the data we have.
From our partners.We have information agencies as partners and they are located worldwide, thus we get (or purchase) the latest data from them.
Via our long-term tracking and gathering of data from this industry.We have a database that contains history data regarding the market.
About Us:
Global Info Research
Web: https://www.globalinforesearch.com
Email: report@globalinforesearch.com
Global Info Research is a company that digs deep into global industry information to support enterprises with market strategies and in-depth market development analysis reports. We provides market information consulting services in the global region to support enterprise strategic planning and official information reporting, and focuses on customized research, management consulting, IPO consulting, industry chain research, database and top industry services. At the same time, Global Info Research is also a report publisher, a customer and an interest-based suppliers, and is trusted by more than 30,000 companies around the world. We will always carry out all aspects of our business with excellent expertise and experience.
According to our (Global Info Research) latest study, the global N,N'-Carbonyldiimidazole (CDI) market size was valued at US$ 23.22 million in 2025 and is forecast to a readjusted size of US$ 27.71 million by 2032 with a CAGR of 3.1% during review period. N,N′-Carbonyldiimidazole (also written as 1,1′-carbonyldiimidazole, abbreviated as CDI; CAS 530-62-1, molecular formula C₇H₆N₄O) is a versatile reagent used in numerous chemical synthesis processes as a safer equivalent to phosgene. It functions as an efficient coupling and activation agent in the formation of amides, esters, and carbonyl compounds. Due to its stability and reliable performance, it is widely applied in pharmaceutical and industrial production, making it a valuable intermediate in fine and specialty chemical manufacturing. In 2025, global production of N,N′-Carbonyldiimidazole (CDI) reached approximately 1,328 tons, with an average global market price of around US$ 17/kg. The gross profit margin is approximately 20%-30%. Gradual growth, niche scale: CDI demand typically expands at a moderate pace because it is tied to specific synthesis routes (pharma intermediates, peptides) rather than broad commodity uses. Often campaign / make-to-order production: Many suppliers prefer to organize production by batch/order rather than large-scale upfront stockpiling. Substitution competition is real in amide/peptide coupling: CDI competes with alternative coupling strategies and reagents (e.g., T3P, HATU in some settings) and with process designs aiming to reduce coupling-reagent usage. Development speed varies across regions: Asia-Pacific growth is expected to be faster, led by China and India. In parallel, the market shows increasing China/India-based supply depth, supporting faster regional expansion. Technology trend: Better yield and waste reduction via imidazole recycle loops. Patented industrial routes emphasize neutralizing the imidazole·HCl by-product and recycling imidazole back into CDI production, targeting cost reduction and more sustainable operations. This report is a detailed and comprehensive analysis for global N,N'-Carbonyldiimidazole (CDI) market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Sample Report Request N,N'-Carbonyldiimidazole (CDI)
https://www.globalinforesearch.com/reports/3624566/n-n--carbonyldiimidazole--cdi
Market segment by Type: Purity≥98%、 Purity＜98%
Market segment by Application: Pharmaceuticals、 Peptide Synthesis、 Others
Major players covered: Lanxess、 Hodogaya Chemical、 Atul、 GREEN Life Science、 Jiangxi Jinkai Chemical、 Zhejiang HuTu PharmChem、 Holdenchem、 Jiangsu Zhenri Chemical
Market segment by region, regional analysis covers:
North America (United States, Canada and Mexico),
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe),
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia),
South America (Brazil, Argentina, Colombia, and Rest of South America),
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa).
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe N,N'-Carbonyldiimidazole (CDI) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of N,N'-Carbonyldiimidazole (CDI), with price, sales, revenue and global market share of N,N'-Carbonyldiimidazole (CDI) from 2021 to 2025.
Chapter 3, the N,N'-Carbonyldiimidazole (CDI) competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the N,N'-Carbonyldiimidazole (CDI) breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2021 to 2025.and N,N'-Carbonyldiimidazole (CDI) market forecast, by regions, type and application, with sales and revenue, from 2026 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of N,N'-Carbonyldiimidazole (CDI).
Chapter 14 and 15, to describe N,N'-Carbonyldiimidazole (CDI) sales channel, distributors, customers, research findings and conclusion.
Data Sources:
Via authorized organizations:customs statistics, industrial associations, relevant international societies, and academic publications etc.
Via trusted Internet sources.Such as industry news, publications on this industry, annual reports of public companies, Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), Trading Economics, News Network, Statista, Federal Reserve Economic Data, BIS Statistics, ICIS, Companies House Documentsm, investor presentations, SEC filings of companies, etc.
Via interviews. Our interviewees includes manufacturers, related companies, industry experts, distributors, business (sales) staff, directors, CEO, marketing executives, executives from related industries/organizations, customers and raw material suppliers to obtain the latest information on the primary market;
Via data exchange. We have been consulting in this industry for 16 years and have collaborations with the players in this field. Thus, we get access to (part of) their unpublished data, by exchanging with them the data we have.
From our partners.We have information agencies as partners and they are located worldwide, thus we get (or purchase) the latest data from them.
Via our long-term tracking and gathering of data from this industry.We have a database that contains history data regarding the market.
About Us:
Global Info Research
Web: https://www.globalinforesearch.com
Email: report@globalinforesearch.com
Global Info Research is a company that digs deep into global industry information to support enterprises with market strategies and in-depth market development analysis reports. We provides market information consulting services in the global region to support enterprise strategic planning and official information reporting, and focuses on customized research, management consulting, IPO consulting, industry chain research, database and top industry services. At the same time, Global Info Research is also a report publisher, a customer and an interest-based suppliers, and is trusted by more than 30,000 companies around the world. We will always carry out all aspects of our business with excellent expertise and experience.
